125 related articles for article (PubMed ID: 21549094)
21. Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells.
Yamazaki H; Naito M; Ghani FI; Dang NH; Iwata S; Morimoto C
Biochem Biophys Res Commun; 2012 Mar; 419(3):529-36. PubMed ID: 22369943
[TBL] [Abstract][Full Text] [Related]
22. Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
Neudenberger J; Hotfilder M; Rosemann A; Langebrake C; Reinhardt D; Pieters R; Schrauder A; Schrappe M; Röttgers S; Harbott J; Vormoor J
Br J Haematol; 2006 May; 133(3):337-44. PubMed ID: 16643437
[TBL] [Abstract][Full Text] [Related]
23. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
Muntean AG; Hess JL
Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
[TBL] [Abstract][Full Text] [Related]
24. Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients.
De Bruyne E; Andersen TL; De Raeve H; Van Valckenborgh E; Caers J; Van Camp B; Delaissé JM; Van Riet I; Vanderkerken K
Leukemia; 2006 Oct; 20(10):1870-9. PubMed ID: 16900214
[TBL] [Abstract][Full Text] [Related]
25. CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells.
Yamazaki H; Nishida H; Iwata S; Dang NH; Morimoto C
Biochem Biophys Res Commun; 2009 May; 383(2):172-7. PubMed ID: 19341705
[TBL] [Abstract][Full Text] [Related]
26. Tetraspanin CD9 regulates osteoclastogenesis via regulation of p44/42 MAPK activity.
Yi T; Kim HJ; Cho JY; Woo KM; Ryoo HM; Kim GS; Baek JH
Biochem Biophys Res Commun; 2006 Aug; 347(1):178-84. PubMed ID: 16808899
[TBL] [Abstract][Full Text] [Related]
27. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
28. High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias.
Lasa A; Serrano E; Carricondo M; Carnicer MJ; Brunet S; Badell I; Sierra J; Aventín A; Nomdedéu JF
Ann Hematol; 2008 Mar; 87(3):205-11. PubMed ID: 17909799
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of the human CD9 gene: characterization of the 5'-flanking region.
Le Naour F; Prenant M; Francastel C; Rubinstein E; Uzan G; Boucheix C
Oncogene; 1996 Aug; 13(3):481-6. PubMed ID: 8760289
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.
Eißmann M; Melzer IM; Fernández SB; Michel G; Hrabě de Angelis M; Hoefler G; Finkenwirth P; Jauch A; Schoell B; Grez M; Schmidt M; Bartholomae CC; Newrzela S; Haetscher N; Rieger MA; Zachskorn C; Mittelbronn M; Zörnig M
Oncogene; 2013 May; 32(20):2586-91. PubMed ID: 22751129
[TBL] [Abstract][Full Text] [Related]
31. Expression of CD133 on leukemia-initiating cells in childhood ALL.
Cox CV; Diamanti P; Evely RS; Kearns PR; Blair A
Blood; 2009 Apr; 113(14):3287-96. PubMed ID: 19147788
[TBL] [Abstract][Full Text] [Related]
32. The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells.
Ovalle S; Gutiérrez-López MD; Olmo N; Turnay J; Lizarbe MA; Majano P; Molina-Jiménez F; López-Cabrera M; Yáñez-Mó M; Sánchez-Madrid F; Cabañas C
Int J Cancer; 2007 Nov; 121(10):2140-52. PubMed ID: 17582603
[TBL] [Abstract][Full Text] [Related]
33. Ph+/VE-cadherin+ identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells.
Wang L; O'Leary H; Fortney J; Gibson LF
Blood; 2007 Nov; 110(9):3334-44. PubMed ID: 17638851
[TBL] [Abstract][Full Text] [Related]
34. Osteoblast-enriched membrane protein IFITM5 regulates the association of CD9 with an FKBP11-CD81-FPRP complex and stimulates expression of interferon-induced genes.
Hanagata N; Li X
Biochem Biophys Res Commun; 2011 Jun; 409(3):378-84. PubMed ID: 21600883
[TBL] [Abstract][Full Text] [Related]
35. CD9 antigen on acute non-lymphoid leukemia cells: preferential expression by promyelocytic (M3) subtype.
Ferrero D; Carlesso N; Gallo E; Pregno P; De Fabritiis P; Petti MC; Mandelli F
Leuk Res; 1991; 15(6):457-61. PubMed ID: 1861531
[TBL] [Abstract][Full Text] [Related]
36. CD9 knockdown suppresses cell proliferation, adhesion, migration and invasion, while promoting apoptosis and the efficacy of chemotherapeutic drugs and imatinib in Ph+ ALL SUP‑B15 cells.
Xing C; Xu W; Shi Y; Zhou B; Wu D; Liang B; Zhou Y; Gao S; Feng J
Mol Med Rep; 2020 Oct; 22(4):2791-2800. PubMed ID: 32945456
[TBL] [Abstract][Full Text] [Related]
37. Colocalisation of CD9 and mortalin in CD9-induced mitotic catastrophe in human prostate cancer cells.
Zvereff V; Wang JC; Shun K; Lacoste J; Chevrette M
Br J Cancer; 2007 Oct; 97(7):941-8. PubMed ID: 17848953
[TBL] [Abstract][Full Text] [Related]
38. Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia.
Boag JM; Beesley AH; Firth MJ; Freitas JR; Ford J; Hoffmann K; Cummings AJ; de Klerk NH; Kees UR
Leukemia; 2006 Oct; 20(10):1731-7. PubMed ID: 17041637
[TBL] [Abstract][Full Text] [Related]
39. Transmembrane TNF-α preferentially expressed by leukemia stem cells and blasts is a potent target for antibody therapy.
Zhou X; Zhou S; Li B; Li Q; Gao L; Li D; Gong Q; Zhu L; Wang J; Wang N; Huang L; Zhao L; Li Z; Zhou J
Blood; 2015 Sep; 126(12):1433-42. PubMed ID: 26224647
[TBL] [Abstract][Full Text] [Related]
40. Disruption of Annexin II /p11 Interaction Suppresses Leukemia Cell Binding, Homing and Engraftment, and Sensitizes the Leukemia Cells to Chemotherapy.
Gopalakrishnapillai A; Kolb EA; Dhanan P; Mason RW; Napper A; Barwe SP
PLoS One; 2015; 10(10):e0140564. PubMed ID: 26465153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]